ROCHESTER, N.Y., May 11, 2012 (GLOBE NEWSWIRE) -- NaturalNano, Inc. (OTCBB:NNAN) announced that it has retained the firm of Park Avenue Investor Relations based in Rochester, NY to provide investor relations (IR) services to NaturalNano. Park Avenue IR was founded by top-ranked analyst and IR executive Tom Morabito and provides a full range of investor services including investor outreach and targeting, financial results and media support.
NaturalNano's CEO James Wemett commented, "We are excited to announce our relationship with Park Avenue IR. Tom Morabito has nearly 20 years of investor relations, finance, and capital markets experience. We believe that he and his team will be a tremendous resource for NaturalNano as our business continues to expand. Park Avenue IR has the skill and experience to get our exciting story out to a broader group of investors."
About NaturalNano, Inc.:
NaturalNano, Inc. (OTCBB:NNAN) is a materials science company focused on developing and commercializing advanced nanocomposites. The Company is focused on additive technologies and processes, including its proprietary Pleximer that adds value to industrial polymers, plastics and composites. NaturalNano holds and/or licenses 20 patents and applications relating to Halloysite, as well as proprietary know-how for its extraction and separation processes, compositions, and derivatives. http://www.naturalnano.com/">www.naturalnano.com
About Park Avenue Investor Relations, LLC:
Park Avenue Investor Relations was founded by a top-ranked equity analyst who also led the in-house investor relations (IR) programs for three industry leading companies. Based in Rochester, N.Y., Park Avenue takes a unique finance and capital markets based approach to IR in offering its clients an extensive array of comprehensive services. Additional information is available at http://www.parkavenueir.com/">www.parkavenueir.com.
Cautionary Statement Regarding Forward-Looking Statements: Contains forward-looking statements regarding future events and future performance that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-K and quarterly reports on Form 10-Q filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.